TytoCare, pioneer of remote physical examination technology featuring FDA-cleared medical devices, announced the appointment of Adam Pellegrini as Chief Executive Officer alongside the closing of a $25 million-plus growth round led by Insight Partners, with participation from HOOP, OliveTree, OrbiMed, Qumra Capital, Qualcomm Ventures, and others. The company is expanding its platform to deliver clinical-grade remote care for patients with chronic and complex disease, repositioning as an AI-first clinical enablement platform.
Pellegrini brings more than two decades of experience at the intersection of digital health, consumer health technology, and large-scale clinical programs. His appointment comes as the company moves to embed its remote examination platform and FDA-cleared AI-powered software as a medical device algorithms directly into integrated care pathways for remote cardiopulmonary monitoring, oncology support, and complex chronic disease management. The company’s platform combines a handheld examination device capable of capturing clinical-grade heart, lung, ear, skin, throat, and abdomen data with a suite of FDA-cleared AI algorithms that enable clinicians to conduct comprehensive remote physical exams with diagnostic confidence previously achievable only in person.
The oversubscribed financing round reflects institutional conviction in the company’s market position and accelerating commercial demand for AI-enabled remote diagnostics. Proceeds will fund expansion of the company’s AI clinical algorithms pipeline, deepen payer and health system partnerships, and accelerate go-to-market efforts targeting chronic and serious disease populations, including cardiometabolic patients, those undergoing cancer treatment, and post-acute care transitions. Alongside Pellegrini, the company also announced the appointment of Greg Orr, former Vice President of Digital Health at Walgreens and COO of Jasper Health, as Chief Operating Officer.
TytoCare is headquartered in New York and Netanya, Israel, and partners with leading health systems, insurers, and employer health programs globally. Insight Partners is a global software investor with more than $90 billion in regulatory assets under management as of December 31, 2025, having invested in more than 900 companies worldwide with over 55 portfolio companies achieving an IPO.
KEY QUOTES:
“The convergence of a clinically validated exam device, AI-powered diagnostic algorithms, and the urgent demand from health systems for real clinical intelligence at the point of virtual care is an extraordinary and rare combination. TytoCare has built the foundational infrastructure for the next generation of intelligent remote care, and I could not be more energized to lead this next chapter.”
Adam Pellegrini, Chief Executive Officer, TytoCare
“Health systems have wanted to extend real clinical care into the home for years. The barrier has long been diagnostic fidelity. TytoCare takes a new approach: an FDA-cleared exam device paired with AI algorithms that keep improving as the evidence base grows. That combination is genuinely hard to replicate, and it becomes more defensible over time, not less. We believe Adam is the right operator to take this into health systems at scale, and this is the right moment to do it.”
Jeff Horing, Managing Director, Insight Partners
